Assignee
CRYSTAL PHARMATECH CO LTD
CN·20 granted patents·7 pending applications·14 citations·filing 2014–2023
Top patents by PatentIndex Score
27 records- 0191US10246418B2Crystal form of lenvatinib methanesulfonate salt and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Apr 2, 2019·6 cites·9 claims
- 0285US10577334B2Crystalline form E of tafamidis meglumine, process for preparation and use thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Granted Mar 3, 2020·2 cites·9 claims
- 0384US9994579B2Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of saltCRYSTAL PHARMATECH CO LTD·Filed 2015·Granted Jun 12, 2018·3 cites·10 claims
- 0471US9957240B2Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereofCRYSTAL PHARMATECH CO LTD·Filed 2015·Granted May 1, 2018·1 cites·19 claims
- 0569US10377757B2Crystal form of JAK inhibitor and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Aug 13, 2019·1 cites·1 claims
- 0668US10323035B2Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Jun 18, 2019·1 cites·19 claims
- 0759US2023265056A1Crystalline forms of benzamide compound and process for preparing the sameCRYSTAL PHARMATECH CO LTD·Filed 2023·Application pending·0 cites
- 0858US10138250B2Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of saltCRYSTAL PHARMATECH CO LTD·Filed 2018·Granted Nov 27, 2018·0 cites·8 claims
- 0956US10544129B2Crystalline forms of AP26113, and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Granted Jan 28, 2020·0 cites·14 claims
- 1056US10266523B2Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Apr 23, 2019·0 cites·22 claims
- 1154US10351536B2Crystalline forms of lesinurad and its sodium saltCRYSTAL PHARMATECH CO LTD·Filed 2014·Granted Jul 16, 2019·0 cites·5 claims
- 1253US10562855B2Crystalline form of lenvantinib mesylate and process of preparation thereofCRYSTAL PHARMATECH CO LTD·Filed 2019·Granted Feb 18, 2020·0 cites·7 claims
- 1353US2023416207A1Crystalline forms of quinazolinone compound and process for preparing the sameCRYSTAL PHARMATECH CO LTD·Filed 2021·Application pending·0 cites
- 1452US10308641B2Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Jun 4, 2019·0 cites·8 claims
- 1550US2024018155A1New crystal form of p-toluenesulfonate salt of diazabicyclic compound and preparation method thereforCRYSTAL PHARMATECH CO LTD·Filed 2021·Application pending·0 cites
- 1647US10487064B1Crystalline forms of selective S1P1 receptor modulator and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Nov 26, 2019·0 cites·20 claims
- 1747US10472369B2Crystalline forms of (6-(1H-indazol-6-yl)-N-[4-(4-(4-morpholinyl)phenyl]imidazo[1,2-A]pyrazin-8-amine) methanesulfonateCRYSTAL PHARMATECH CO LTD·Filed 2017·Granted Nov 12, 2019·0 cites·29 claims
- 1846US2016280731A1CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZINCRYSTAL PHARMATECH CO LTD·Filed 2014·Application pending·0 cites
- 1945US10233144B2Crystalline form of AHU377, preparation method and use thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·15 claims
- 2044US10273262B2Crystalline form A of obeticholic acid and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2015·Granted Apr 30, 2019·0 cites·11 claims
- 2144US10246437B2Crystal form of neratinib maleate and preparation method thereforCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Apr 2, 2019·0 cites·25 claims
- 2244US10138239B2Preparation method of crystalline form a of PCI-32765CRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Nov 27, 2018·0 cites·17 claims
- 2343US10196395B2Crystalline form alpha of IPI-145 and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Feb 5, 2019·0 cites·11 claims
- 2442US2023203040A1Crystalline forms of a sulfonamide compound and processes for preparing the sameCRYSTAL PHARMATECH CO LTD·Filed 2021·Application pending·0 cites
- 2541US10442775B2Preparation method for eutectic hydrate crystal form II of AHU-377 and diovan trisodium saltCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Oct 15, 2019·0 cites·20 claims
- 2640US2019100519A1Hydrochloride salt crystal of drug for treating or preventing jak-associated disease and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Application pending·0 cites
- 2739US2019092756A1Crystalline form a of 2-[(2r)-2-methyl-2-pyrrolidyl]-1h-benzimidazole-7-carboxamide dihydrochloride and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →